Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Nvidia’s stock has a leg to go much higher, says Freedom Capital’s Jay Woods
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Jay Woods, Freedom Capital Markets chief global strategist, joins ‘Power Lunch’ to discuss the technical support for three stocks making some moves today.
The big picture with Nvidia has not really changed, says BofA’s Arya
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Vivek Arya, Bank of America Securities semiconductor analyst, joins ‘The Exchange to discuss Nvidia, which reports earnings after the bell tomorrow. He also weighs in on Intel. 05:13 Tue, Aug 23 20221:57 PM EDT
Q4 or Q1 is the bottom of the cycle for semi stocks, says Bank of America’s Arya
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Vivek Arya, Bank of America managing director, joins ‘TechCheck’ to discuss the most ‘obvious trade’ over the next several years, what will happen to these stocks in the next year and the implications of the recent TSMC investment in the U.S. 04:31…
Lightning Round: IBM is inexpensive and ‘a pretty good stock’, says Jim Cramer
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email ‘Mad Money’ host Jim Cramer weighs in on viewer stock picks including: MBIA, Whirlpool, Carnival Cruise Line, Modine Manufacturing, DraftKings and IBM. 04:49 Thu, Dec 14 20237:52 PM EST
This upcoming event could turn the market into a ‘minefield,’ says Peter Boockvar
Brace yourselves. The U.S. stock market could become a “minefield” this upcoming earnings season as companies begin to feel the heat from slowing economies around the globe, warns Peter Boockvar, chief investment officer at Bleakley Financial Group. “Earnings, I think, are going to be that minefield,” he said Thursday on CNBC’s “Futures Now.” “You’re going to…
Options Action: Traders making big bets on Uber
Mike Khouw, Optimize Advisors president, joins the Options Action traders to talk big bets on Uber.
